MDM2 and breast cancer: MDM2 splice variants MDM2-B and MDM2-C have longer half-lives than full-length MDM2 protein after chemotherapy, and MDM2-C can act as an E3 ubiquitin ligase to induce apoptosis in breast cancer cells [39].